You are here

Home › USG awards $500 million to companies for developing spray, pill COVID vaccines › USG awards $500 million to companies for developing spray, pill COVID vaccines

USG awards $500 million to companies for developing spray, pill COVID vaccines

Primary tabs

USG awards $500 million to companies for developing spray, pill COVID vaccines

Mon, 2024-06-17 17:56 — mike kraft
Feds award $500 million for developing spray, pill COVID vaccines The vast majority of funds—up to $453 million—goes to Vaxart of San Francisco for developing an oral pill vaccine candidate. CIDRAP

 

 

Country / Region Tags: 
United States
General Topic Tags: 
COVID-19
Boosters
Government
Health
Public Health
Research
Vaccinations
Problem, Solution, SitRep, or ?: 
Situation Report
Groups this Group Post belongs to: 
Global Health
Medical - global
Vaccines
- Private group -
Workflow history
Revision ID Field name Date Old state New state name By Commentaire Operations
No state No state
howdy folks